On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes

Authors: Schaller, H. C.; Schaupp, L.; Bodenlenz, M.; Wilinska, M. E.1; Chassin, L. J.1; Wach, P.2; Vering, T.3; Hovorka, R.1; Pieber, T. R.4

Source: Diabetic Medicine, Volume 23, Number 1, January 2006 , pp. 90-93(4)

Publisher: Blackwell Publishing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Aims 

To evaluate an algorithm with glucose prediction capacity and continuous adaptation of patient parameters—a model predictive control (MPC) algorithm—to control blood glucose concentration during fasting conditions in patients with Type 1 diabetes. In the subcutaneous (sc) route within a closed loop system. Methods 

Paired experiments were performed in six patients. Over 8 h the MPC algorithm was used to control glucose with s.c. insulin administration and two different glucose monitoring protocols: first, the algorithm was provided with intravenous (i.v.) glucose values for insulin dosage calculation directly (i.v.–s.c. route). Then, in the second experiment, i.v. glucose values were fed to the MPC with a delay of 30 min to simulate s.c. glucose measurements (‘s.c.’–s.c. route). In both experiments plasma glucose, insulin dosage, and serum insulin levels were analysed. Results 

Glucose concentration was brought from hyper- to normoglycaemia and kept in the physiological range (6–7 mmol/l) with both routes in all subjects. Mean glucose concentration reached the threshold of 7 mmol/l approximately 2 (i.v.–s.c. route) and 3 (‘s.c.’–s.c. route) hours after the start of glucose control with the MPC. During the last 2 h of automated glucose control, mean glucose concentration was 6.3 ± 0.2 mmol/l and 6.6 ± 0.3 mmol/l for i.v.–s.c. and ‘s.c.’–s.c. route, respectively. Glucose concentration, insulin doses, and serum insulin levels did not differ significantly between routes (P > 0.05). Conclusions 

The MPC algorithm is suitable for glucose control during fasting within an extracorporeal artificial β-cell in the subcutaneous route Type 1 diabetic patients.

Diabet. Med. 23, 90–93 (2006)

Keywords: algorithms; artificial β-cell; continuous subcutaneous insulin infusion; glucose control; glucose monitoring

Document Type: Research article

DOI: 10.1111/j.1464-5491.2006.01695.x

Affiliations: 1: Diabetes Modelling Group, Department of Paediatrics, University of Cambridge, Cambridge, UK, and 2: Department of Biophysics, Institute of Biomedical Engineering, University of Technology Graz and 3: Disetronic Medical Systems AG, Burgdorf, Switzerland 4: Department of Internal Medicine, Diabetes and Metabolism, Medical University Graz, Graz, Austria,

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$50.39 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A